BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19049515)

  • 21. Identification by mutagenesis of conserved arginine and glutamate residues in the C-terminal domain of rat liver carnitine palmitoyltransferase I that are important for catalytic activity and malonyl-CoA sensitivity.
    Treber M; Dai J; Woldegiorgis G
    J Biol Chem; 2003 Mar; 278(13):11145-9. PubMed ID: 12540837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity of the interactions between Glu-3, Ser-24, and Gln-30 within the N-terminal segment of rat liver mitochondrial overt carnitine palmitoyltransferase (L-CPT I) in determining the malonyl-CoA sensitivity of the enzyme.
    Jackson VN; Price NT; Zammit VA
    Biochemistry; 2001 Dec; 40(48):14629-34. PubMed ID: 11724576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carnitine palmitoyltransferase in the heart is controlled by a different mechanism than the hepatic enzyme.
    Cook GA; Lappi MD
    Mol Cell Biochem; 1992 Oct; 116(1-2):39-45. PubMed ID: 1480153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased sensitivity of carnitine palmitoyltransferase I activity to malonyl-CoA inhibition after preincubation of intact rat liver mitochondria with micromolar concentrations of malonyl-CoA in vitro.
    Zammit VA
    Biochem J; 1983 Mar; 210(3):953-6. PubMed ID: 6870813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle.
    Kim JY; Koves TR; Yu GS; Gulick T; Cortright RN; Dohm GL; Muoio DM
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1014-22. PubMed ID: 11934665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hysteretic behaviour of carnitine palmitoyltransferase. The effect of preincubation with malonyl-CoA.
    Cook GA; Cox KA
    Biochem J; 1986 Jun; 236(3):917-9. PubMed ID: 3790097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the malonyl-CoA-sensitive carnitine palmitoyltransferase (CPTo) of a rat heart mitochondrial particle. Evidence that the catalytic unit is CPTi.
    Kerner J; Zaluzec E; Gage D; Bieber LL
    J Biol Chem; 1994 Mar; 269(11):8209-19. PubMed ID: 8132545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Packing of transmembrane domain 2 of carnitine palmitoyltransferase-1A affects oligomerization and malonyl-CoA sensitivity of the mitochondrial outer membrane protein.
    Jenei ZA; Warren GZ; Hasan M; Zammit VA; Dixon AM
    FASEB J; 2011 Dec; 25(12):4522-30. PubMed ID: 21917985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mitochondrial intermembrane loop region of rat carnitine palmitoyltransferase 1A is a major determinant of its malonyl-CoA sensitivity.
    Borthwick K; Jackson VN; Price NT; Zammit VA
    J Biol Chem; 2006 Nov; 281(44):32946-52. PubMed ID: 16908527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pH and acyl-CoA chain length on the conversion of heart mitochondrial CPT-I/CPTo to a high affinity, malonyl-CoA-inhibited state.
    Bieber LL; Wagner M
    Biochim Biophys Acta; 1996 Aug; 1290(3):261-6. PubMed ID: 8765129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition by functional and structural analysis of two malonyl-CoA sites in carnitine palmitoyltransferase 1A.
    López-Viñas E; Bentebibel A; Gurunathan C; Morillas M; de Arriaga D; Serra D; Asins G; Hegardt FG; Gómez-Puertas P
    J Biol Chem; 2007 Jun; 282(25):18212-18224. PubMed ID: 17452323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the sensitivity of carnitine palmitoyltransferase to inhibition by malonyl-CoA are due to differences in Ki values.
    Cook GA
    J Biol Chem; 1984 Oct; 259(19):12030-3. PubMed ID: 6480597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carnitine palmitoyl transferase I and the control of beta-oxidation in heart mitochondria.
    Eaton S; Bartlett K; Quant PA
    Biochem Biophys Res Commun; 2001 Jul; 285(2):537-9. PubMed ID: 11444876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of conserved amino acid residues in rat liver carnitine palmitoyltransferase I critical for malonyl-CoA inhibition. Mutation of methionine 593 abolishes malonyl-CoA inhibition.
    Morillas M; Gómez-Puertas P; Bentebibel A; Sellés E; Casals N; Valencia A; Hegardt FG; Asins G; Serra D
    J Biol Chem; 2003 Mar; 278(11):9058-63. PubMed ID: 12499375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C75 activates malonyl-CoA sensitive and insensitive components of the CPT system.
    Nicot C; Napal L; Relat J; González S; Llebaria A; Woldegiorgis G; Marrero PF; Haro D
    Biochem Biophys Res Commun; 2004 Dec; 325(3):660-4. PubMed ID: 15541339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethanol increases the sensitivity of carnitine palmitoyltransferase I to inhibition by malonyl-CoA in short-term hepatocyte incubations.
    Guzmán M; Castro J
    Biochim Biophys Acta; 1989 Apr; 1002(3):405-8. PubMed ID: 2713390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a cDNA for rat liver carnitine palmitoyltransferase I in yeast establishes that catalytic activity and malonyl-CoA sensitivity reside in a single polypeptide.
    Brown NF; Esser V; Foster DW; McGarry JD
    J Biol Chem; 1994 Oct; 269(42):26438-42. PubMed ID: 7929364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver mitochondria, confirmed as intact by complete suppression of succinate uptake and oxidation, possess a carnitine palmitoyltransferase I that is totally inhibited by malonyl CoA.
    Abo-Hashema KA; Cake MH; Potter IC
    Biochem Biophys Res Commun; 1999 May; 258(3):778-83. PubMed ID: 10329463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
    Thupari JN; Pinn ML; Kuhajda FP
    Biochem Biophys Res Commun; 2001 Jul; 285(2):217-23. PubMed ID: 11444828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.